Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Thrombospondin 1 ELISA Kit (AC3263)
Cat.#: ASET-1852
Specifications
Description Mouse Thrombospondin 1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Thrombospondin 1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.53 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 30-480 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1198 Rat CD147 ELISA Kit (AC2609) Quantitative inquiry ASET-1153 Human Plexin A4 ELISA Kit (AC2564) Quantitative inquiry ASET-2027 Human Prion Protein PrP ELISA Kit (AC3438) Quantitative inquiry ASET-1658 ACTH ELISA Kit (AC3069) Quantitative inquiry ASET-1612 Human Nyctalopin ELISA Kit (AC3023) Quantitative inquiry ASET-2418 Human CXCL11 ELISA Kit (AC3829) Quantitative inquiry ASET-1092 Guinea Pig PEDF ELISA Kit (AC2503) Quantitative inquiry ASET-1544 Human ODZ3 ELISA Kit (AC2955) Quantitative inquiry ASET-1370 Mouse C3 ELISA Kit (AC2781) Quantitative inquiry ASET-1873 Mouse Sprn ELISA Kit (AC3284) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket